A. Lemoine et al., PROSPECTIVE EVALUATION OF CIRCULATING HEPATOCYTES BY ALPHA-FETOPROTEIN MESSENGER-RNA IN HUMANS DURING LIVER SURGERY, Annals of surgery, 226(1), 1997, pp. 43-50
Objective The objective of this study was to analyze the specificity o
f detecting liver tumor cell dissemination by alpha-fetoprotein (AFP)
mRNA in peripheral blood. Summary Background Data Alpha-fetoprotein mR
NA has been used for the detection of circulating micrometastatic tumo
r foci of hepatocellular carcinoma (HCC); however, the interpretation
of the results has been equivocal. Methods Sixty-four consecutive pati
ents with malignant HCC (n = 20), liver metastases (n = 27), or nonmal
ignant (n = 17) liver diseases undergoing partial or total hepatectomy
and orthotopic liver transplantation were included in this prospectiv
e study from January to July 1995. Peripheral blood samples were obtai
ned before surgery, during surgery, and after surgery (range, 6-15 mon
ths). Total mRNA was extracted from nucleated cells, and cDNA synthesi
s and polymerase chain reaction amplification (nested polymerase chain
reaction in one tube) were performed with specific AFP primers. Resul
ts Preoperative AFP mRNA was detected in 20 patients (17%), of which 5
of 20 had HCC. Intraoperative assessment showed positive AFP mRNA val
ues in a total of 34 patients (53%) with various causes, of which 8 of
20 (40%) had HCC, 17 of 27 (63%) had other malignancies, and 9 of 17
(53%) had nonmalignant diseases. Recurrent tumor in patients with HCC
occurred in four cases after surgery (range, 6-15 months) and did not
correlate with AFP mRNA positivity before surgery, during surgery, or
after surgery, Conclusions Alpha-fetoprotein mRNA in peripheral blood
is not a specific marker of circulating micrometastases from HCC, espe
cially in the context of surgical treatment of HCC.